Trials / Completed
CompletedNCT03750721
Staphylococcal Acute Post-Operative PJI Treated With 'DAIR' And Impact Of Rifampin
Staphylococcal Acute Post-Operative Prosthetic Joint Infection Treated With 'DAIR' (Debridement and Implant Retention) And Impact Of Rifampin: A Retrospective Cohort Study In France
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 79 (actual)
- Sponsor
- Hospices Civils de Lyon · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- —
Summary
S. aureus and coagulase-negative staphylococci are the most frequent bacteria responsible for PJI (prosthetic joint infection). The aim of this study is to describe the use of rifampicin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Role of rifampin in staphylococcal PJI | the aim is to determine if the dose and the duration of rifampin influenced the prognosis |
Timeline
- Start date
- 2018-04-01
- Primary completion
- 2018-05-01
- Completion
- 2018-05-01
- First posted
- 2018-11-23
- Last updated
- 2018-11-23
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03750721. Inclusion in this directory is not an endorsement.